Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD

Primary Care Respiratory Journal

Volumn 15, Issue 3, 2006, Pages 139-142

  Celli, Bartolome ^a   Cross, Sue ^b   Grossman, Ronald ^c   Kardos, Peter ^d   Myrseth, Svein Erik ^e   Rodriguez Roisin, Roberto ^f   Vestbo, Jørgen ^g  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b Bedfordshire and Hertfordshire ^*  (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

^d Maingau Krankenhaus   (Germany)

^e European Federation of Allergy and Airways Disease Patients Associations   (Norway)

^f UNIVERSITY OF BARCELONA   (Spain)

^g WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE; IPRATROPIUM BROMIDE; MUCOLYTIC AGENT; SALMETEROL; TIOTROPIUM BROMIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; EDITORIAL; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MEDICAL PRACTICE; MEDICAL SOCIETY; OXYGEN THERAPY; PHYSICIAN; PRACTICE GUIDELINE; QUALITY OF LIFE; TREATMENT FAILURE;

BRONCHODILATOR AGENTS; HUMANS; PATIENT CARE TEAM; PRACTICE GUIDELINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE;

EID: 33744530259     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.1016/j.pcrj.2006.02.008     Document Type: Editorial

References (24)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2005. Accessed from www.goldcopd.com on 12 January 2006.
2. Wouters E.F.M. The societal impact of COPD in North America and Europe: an economic analysis of the Confronting COPD survey. Respir Med 97 Suppl C (2003) S3-S14
3. Donaldson G.C., Seemungal T.A., Bhowmik A., and Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in obstructive pulmonary disease. Thorax 57 (2002) 847-852
4. Seemungal T.A.R., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., and Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1418-1422
5. Connors Jr. A.F., Dawson N.V., Thomas C., et al. Outcomes following acute exacerbations of severe chronic obstructive disease. Am J Respir Crit Care Med 154 (1996) 959-967
6. O'Reilly J, Williams AE, Rice L, Holt K. Incidence and impact of healthcare defined exacerbations amongst a cohort of primary care COPD patients [abstract]. ERS, September 2004.
7. Miravitlles M., Murio C., Guerrero T., Gisbert R, and for the DAFNE Study group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 121 (2002) 1449-1455
8. American Thoracic Society/ European Respiratory Society. Standards for the diagnosis and management of patients with COPD. 2004. Accessed from www-test.thoracic.org/copd on 12 January 2006.
9. Davies L., Angus R.M., and Calverley P.M. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 354 (1999) 456-460
10. Thompson W.H., Nielson C.P., Carvalho P., Charan N.B., and Crowley J.J. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 154 (1996) 407-412
11. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation-a consensus conference report. Chest 116 (1999) 521-534
12. Stockley R.A., O'Brien C., Pye A., and Hill S.L. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 117 (2000) 1638-1645
13. Casaburi R., Mahler D.A., Jones P.W., et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Resp J 19 (2002) 217-224
14. Vincken W., van Noord J.A., Greefhorst A.P., et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 19 (2002) 209-216
15. van Noord J.A., de Munck D.R., Bantje T.A., Hop W.C., Akveld M.L., and Bommer A.M. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. Eur Respir J 15 (2000) 878-885
16. Burge P.S., Calverley P.M., Jones P.W., Spencer S., Anderson J.A., and Maslen T.K. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320 (2000) 1297-1303
17. Calverley P., Pauwels R., Vestbo J., et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 361 (2003) 449-456
18. Wouters E.F.M., Postma D.S., Fokkens B., et al. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deteriorations: a randomized controlled trial. Thorax 60 (2005) 480-487
19. Szafranski W., Cukier A., Ramirez A., Menga G., Samores R., and Nahebdien S. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 21 (2003) 74-81
20. Poole P.J., and Black P.N. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 322 (2001) 1271-1274
21. Francis R.S., and Spicer C.C. Chemotherapy in chronic bronchitis. Influence of daily penicillin and tetracycline on exacerbations and their cost. BMJ 5169 (1960) 297-303
22. Finnerty J.P., Keeping I., Bullough I., and Jones J. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. Chest 119 (2001) 1705-1710
23. Wilkinson T.M., Donaldson G.C., Hurst J.R., Seemungal T.A., and Wedzicha J.A. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 169 (2004) 1298-1303
24. Hernandez C., Casas A., Escarrabill J., et al. Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur Respir J 21 (2003) 58-67